Christine Parise Cordes

Christine Parise Cordes is a Partner and Co-chair of Rubin and Rudman’s Corporate, Business and Tax Department. She has a diverse practice encompassing corporate, finance and energy matters. Her clients include closely-held private companies, start-ups (including biotechnology, pharmaceutical and tech companies), middle-market private companies, real estate developers and funds, educational institutions, banks and other financial institutions and municipal light plants.

Representative Experience

• Counsel to buyers and sellers in M&A transactions in various industries, including strategic and private equity M&A transactions, transactions involving rollover equity and leveraged buy-outs
• Counsel to issuers in connection with equity financings structured as private placements exempt from securities registration, including assisting with Form D filings and state blue sky law compliance
• Counsel to regional bank in connection with commercial lending
• Counsel to public power clients in connection with energy procurement, including drafting and negotiation of power purchase agreements, interconnection agreements and net metering agreements and negotiation of collateral assignments in connection with supplier financings
• Counsel to private companies that sponsor, co-develop, and arrange tax equity for utility-scale renewable energy projects primarily based in ISO-NE utilizing solar, wind, biofuels, and fuel cell technologies including organization of project entities, assisting in structuring debt and equity financing, negotiation of power purchase agreements, and negotiation of placement agreements
• Counsel to real estate developers in connection with forming real estate joint ventures and raising real estate investment funds
• Counsel to private investment company engaged in making structurally subordinated mezzanine loans and/or preferred equity investments in sponsored tenant-in-common and Delaware statutory trust “DST” investment vehicles nationwide, which are structured to qualify for 1031 like-kind exchange treatment
• Counsel to biotechnology and pharmaceutical companies in connection with venture capital financing, licensing and co-development, and collaboration agreements primarily based in New England
• Counsel to various non-profit clients (including IRC § 501(c)(3) corporations) in connection with organization, filing for federal tax exemption and complying with state and federal operational requirements and regulations pertaining to fundraising

Recognition and Awards

• Named, Massachusetts Lawyers Weekly, “Go To Business Transaction Lawyer”, 2024
• Named, Boston magazine, Top Lawyers, Corporate Law, 2022-2023
• Selected, Massachusetts Rising Stars List, 2013, 2014

Professional and Community Involvement

• Member, Massachusetts Bar Association
• Member, Oregon Bar Association
• Member, Connecticut Bar Association
• Pro bono attorney, Political Asylum Immigration Representation Project (PAIR) (2004–2007)
• Volunteer, Charles River Conservancy. (2005–2007)
• Developments Editor, Boston University School of Law Annual Review of Banking and Financial Law, (2003–2004)